Literature DB >> 22133509

Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.

David R Kaufman1, Fusheng Li, Ashley N Cruz, Steven G Self, Dan H Barouch.   

Abstract

The global sequence diversity of HIV-1 presents a daunting challenge for vaccine development. We investigated whether a heterologous insert prime-boost regimen could expand global coverage by selectively boosting cellular immune responses to conserved epitopes. Rhesus monkeys were primed and boosted with recombinant adenovirus vectors expressing homologous or heterologous HIV-1 Gag sequences that were optimized to focus responses on highly conserved epitopes. We observed comparable responses directed to specific regions of the Gag protein in all experimental groups without evidence of improved coverage or expanded breadth in the heterologous insert group. These data suggest that antigen-independent factors contribute to the immunodominance patterns of vaccine-elicited cellular immune responses.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133509      PMCID: PMC3246049          DOI: 10.1016/j.vaccine.2011.11.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

Review 2.  The molecular basis for public T-cell responses?

Authors:  Vanessa Venturi; David A Price; Daniel C Douek; Miles P Davenport
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

3.  A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Authors:  Sampa Santra; Bette T Korber; Mark Muldoon; Dan H Barouch; Gary J Nabel; Feng Gao; Beatrice H Hahn; Barton F Haynes; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

4.  Towards prediction of degenerate CTL epitope recognition.

Authors:  Fusheng Li; Denise M McKenney; Uma Malhotra; Claire Crimi; Jessica Nolin; Lawrence Corey; Juliana M McElrath; Mark J Newman; Steven G Self
Journal:  Hum Vaccin       Date:  2007-10-26

5.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

6.  Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.

Authors:  Peter Abbink; Angelique A C Lemckert; Bonnie A Ewald; Diana M Lynch; Matthew Denholtz; Shirley Smits; Lennart Holterman; Irma Damen; Ronald Vogels; Anna R Thorner; Kara L O'Brien; Angela Carville; Keith G Mansfield; Jaap Goudsmit; Menzo J E Havenga; Dan H Barouch
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Authors:  Dan H Barouch; Kara L O'Brien; Nathaniel L Simmons; Sharon L King; Peter Abbink; Lori F Maxfield; Ying-Hua Sun; Annalena La Porte; Ambryice M Riggs; Diana M Lynch; Sarah L Clark; Katherine Backus; James R Perry; Michael S Seaman; Angela Carville; Keith G Mansfield; James J Szinger; Will Fischer; Mark Muldoon; Bette Korber
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

8.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Authors:  M Juliana McElrath; Stephen C De Rosa; Zoe Moodie; Sheri Dubey; Lisa Kierstead; Holly Janes; Olivier D Defawe; Donald K Carter; John Hural; Rama Akondy; Susan P Buchbinder; Michael N Robertson; Devan V Mehrotra; Steven G Self; Lawrence Corey; John W Shiver; Danilo R Casimiro
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

9.  Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.

Authors:  Andrej Kosmrlj; Elizabeth L Read; Ying Qi; Todd M Allen; Marcus Altfeld; Steven G Deeks; Florencia Pereyra; Mary Carrington; Bruce D Walker; Arup K Chakraborty
Journal:  Nature       Date:  2010-05-05       Impact factor: 49.962

10.  Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.

Authors:  Jinyan Liu; Kara L O'Brien; Diana M Lynch; Nathaniel L Simmons; Annalena La Porte; Ambryice M Riggs; Peter Abbink; Rory T Coffey; Lauren E Grandpre; Michael S Seaman; Gary Landucci; Donald N Forthal; David C Montefiori; Angela Carville; Keith G Mansfield; Menzo J Havenga; Maria G Pau; Jaap Goudsmit; Dan H Barouch
Journal:  Nature       Date:  2008-11-09       Impact factor: 49.962

View more
  12 in total

1.  DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.

Authors:  Xintao Hu; Antonio Valentin; Frances Dayton; Viraj Kulkarni; Candido Alicea; Margherita Rosati; Bhabadeb Chowdhury; Rajeev Gautam; Kate E Broderick; Niranjan Y Sardesai; Malcolm A Martin; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

2.  HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.

Authors:  Viraj Kulkarni; Antonio Valentin; Margherita Rosati; Morgane Rolland; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

3.  Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.

Authors:  Anne-Marie Carola Andersson; Peter Johannes Holst
Journal:  J Transl Med       Date:  2016-12-20       Impact factor: 5.531

Review 4.  Virus-Like-Vaccines against HIV.

Authors:  Anne-Marie C Andersson; Melanie Schwerdtfeger; Peter J Holst
Journal:  Vaccines (Basel)       Date:  2018-02-11

5.  Using multivalent adenoviral vectors for HIV vaccination.

Authors:  Linlin Gu; Zan C Li; Alexandre Krendelchtchikov; Valentina Krendelchtchikova; Hongju Wu; Qiana L Matthews
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.

Authors:  Viraj Kulkarni; Margherita Rosati; Antonio Valentin; Brunda Ganneru; Ashish K Singh; Jian Yan; Morgane Rolland; Candido Alicea; Rachel Kelly Beach; Gen-Mu Zhang; Sylvie Le Gall; Kate E Broderick; Niranjan Y Sardesai; David Heckerman; Beatriz Mothe; Christian Brander; David B Weiner; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

Review 7.  HIV DNA Vaccine: Stepwise Improvements Make a Difference.

Authors:  Barbara K Felber; Antonio Valentin; Margherita Rosati; Cristina Bergamaschi; George N Pavlakis
Journal:  Vaccines (Basel)       Date:  2014-05-14

8.  HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.

Authors:  Saravana Kanagavelu; James M Termini; Sachin Gupta; Francesca N Raffa; Katherine A Fuller; Yaelis Rivas; Sakhi Philip; Richard S Kornbluth; Geoffrey W Stone
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.

Authors:  Viraj Kulkarni; Antonio Valentin; Margherita Rosati; Candido Alicea; Ashish K Singh; Rashmi Jalah; Kate E Broderick; Niranjan Y Sardesai; Sylvie Le Gall; Beatriz Mothe; Christian Brander; Morgane Rolland; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.

Authors:  Xintao Hu; Zhongyan Lu; Antonio Valentin; Margherita Rosati; Kate E Broderick; Niranjan Y Sardesai; Preston A Marx; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.